Smart hypoxia-responsive sulfated polysaccharides liposomes for controlled and targeted urokinase delivery in thrombotic therapy

Key Points

• Controlled delivery of urokinase using smart liposomes enhances therapeutic outcomes, especially in hypoxic conditions.
• The liposomes are designed to respond to low oxygen levels, releasing urokinase specifically where needed most.
• Analysis involves a novel approach using hypoxia-responsive sulfated polysaccharides to improve drug efficacy.
• The findings highlight the potential for advanced thrombotic therapy strategies, with implications for improving patient outcomes.